News from the FDA/CDC
News from the FDA/CDC
New contact lens elutes antihistamine for ocular allergy
“This is the world’s first and only contact lens that’s able to prevent itching associated with allergies, while at the same time providing vision...
News from the FDA/CDC
Legionnaires’ disease shows steady increase in U.S. over 15+ years
News from the FDA/CDC
FDA OKs first condom for anal sex
Though the CDC has long encouraged the use of a condom during anal intercourse, the FDA had not until now deemed this practice safe.
News from the FDA/CDC
Babies better protected from COVID if mother vaccinated during pregnancy: study
News from the FDA/CDC
Small group of higher-volume antibiotic prescribers identified
Top 10% of Medicare providers “wrote a median of 284 antibiotic prescriptions, compared with a median of 41 among lower-volume prescribers” in...
News from the FDA/CDC
FDA okays new monoclonal antibody that’s effective against Omicron
Bebtelovimab should be used when alternative COVID-19 treatment options approved or authorized by the FDA are not accessible or clinically...
News from the FDA/CDC
CDC issues new pneumococcal vaccine recommendations for adults
PCV15 and PREVNAR20 received approval from the FDA in July 2021, providing an impetus for the revised recommendations.
News from the FDA/CDC
Immunocompromised patients should receive fourth COVID shot: CDC
The CDC contacted pharmacies on Jan. 26 to reinforce the message that people with moderate to severe immune suppression should receive a fourth...
News from the FDA/CDC
FDA approves risankizumab (Skyrizi) for psoriatic arthritis
The approval is the second indication for the anti–interleukin-23 monoclonal antibody after clearance for plaque psoriasis was granted in 2019.
Latest News
Prior COVID infection more protective than vaccination during Delta surge: U.S. study
“The evidence in this report does not change our vaccination recommendations,” said Dr. Ben Silk of the CDC.
News from the FDA/CDC
FDA approves two JAK-1 inhibitors for moderate to severe atopic dermatitis
“It’s big news because a few years ago we didn’t have any systemic treatments that are safer than the classical immunosuppressants.”